New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy

Home > Science Hub > New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Back to the list

April 11, 2024

You might also be interested by

Posters

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

April 27, 2025

More info

Case Studies & Whitepapers

Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology

April 21, 2025

More info

Brochures & Infographics

Advance Your ADC Programs with CellCarta

April 16, 2025

More info

Posters

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

April 7, 2025

More info